These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 28899876

  • 21. Successful application of eculizumab in typical haemolytic uraemic syndrome.
    Hagopian G, Yazdanpanah O, Tran MH, Lee L.
    BMJ Case Rep; 2024 Aug 22; 17(8):. PubMed ID: 39179258
    [Abstract] [Full Text] [Related]

  • 22. Diarrhoea-associated haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infections in New Zealand children: Clinical features and short-term complications from a 23-year cohort study.
    Wong W, Prestidge C, Dickens A, Ronaldson J.
    J Paediatr Child Health; 2023 Mar 22; 59(3):493-498. PubMed ID: 36655863
    [Abstract] [Full Text] [Related]

  • 23. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
    Verhave JC, Wetzels JF, van de Kar NC.
    Nephrol Dial Transplant; 2014 Sep 22; 29 Suppl 4():iv131-41. PubMed ID: 25165180
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A, Ranchin B, King LA, Bacchetta J, Belot A, Gillet Y, Collardeau-Frachon S, Cochat P.
    Arch Pediatr; 2011 Jul 22; 18(7):823-30. PubMed ID: 21571510
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Atypical hemolytic uremic syndrome: from diagnosis to treatment.
    Franchini M.
    Clin Chem Lab Med; 2015 Oct 22; 53(11):1679-88. PubMed ID: 25803082
    [Abstract] [Full Text] [Related]

  • 31. An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab.
    Taton O, Delhaye M, Stordeur P, Goodship T, Le Moine A, Massart A.
    Acta Gastroenterol Belg; 2016 Oct 22; 79(2):257-61. PubMed ID: 27382949
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry.
    Nephrol Dial Transplant; 2012 Oct 22; 27(10):3807-15. PubMed ID: 23114903
    [Abstract] [Full Text] [Related]

  • 34. Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):466-474. PubMed ID: 28339660
    [Abstract] [Full Text] [Related]

  • 35. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

  • 36. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.
    Tajiri H, Nishi J, Ushijima K, Shimizu T, Ishige T, Shimizu M, Tanaka H, Brooks S.
    Int J Antimicrob Agents; 2015 Nov 13; 46(5):586-9. PubMed ID: 26391378
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM.
    Med Clin (Barc); 2015 Nov 20; 145(10):438-45. PubMed ID: 25433773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.